Wellington Partners

Portfolio Companies 2026 for Wellington Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Wellington Partners accounts for 17 tracked companies with verified cap-table data, 17 of which disclose round sizes totalling $1.9B. The median disclosed raise is $90M, and the largest is immatics biotechnologies at $312M, ahead of Beren Therapeutics ($300M) and ImCheck Therapeutics ($154M).

The names that recur most often on these portfolio cap tables are Wellington Partners (17 companies), Andera Partners (5 companies), MIG Capital (3 companies), Kurma Partners (3 companies), Bpifrance (2 companies), Pureos Bioventures (2 companies). By latest disclosed round, the market skews Series B (7), Series A (4), Series C (3), Other Equity (1).

Best funded Wellington Partners companies

  1. immatics biotechnologies — $312M (latest: Other Equity)
  2. Beren Therapeutics — $300M (latest: Growth)
  3. ImCheck Therapeutics — $154M (latest: Series B)
  4. Minervax — $127M
  5. IOmx Therapeutics — $125M (latest: Series B)
  6. MMI — $110M (latest: Series C)
  7. Confo Therapeutics — $106M (latest: Series B)
  8. ENYO Pharma — $102M (latest: Series C)
  9. SNIPR Biome — $90M (latest: Series B)
  10. IconOVir Bio — $77M (latest: Series A)
  11. Tricares — $77M (latest: Series C)
  12. Sidekick Health — $75M (latest: Series B)
  13. SciRhom — $70M (latest: Series A)
  14. CorFlow Therapeutics AG — $60M (latest: Series B)
  15. Aignostics — $54M (latest: Series B)

Wellington Partners — related firms and companies (56)

Wellington Partners profile · All research reports